Double-blind evaluation of oral L-prolyl-Lleucyl-glycine amide in Parkinson's disease.

A 4-month double-blind study comparing the effect of increasing oral doses (up to 1.0 g daily) of synthetic L-proyl-L-leucyl-glycine amide (PLG) and placebo in 20 parkinsonian patients showed no significant improvement in objective scores of functional disability. However, important trends and some...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
Main Authors: Barbeau, A., Roy, M., Kastin, A. J.
Format: Artigo
Jezik:Inglês
Izdano: 1976
Teme:
Research Article
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC1956816/
https://ncbi.nlm.nih.gov/pubmed/3279
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki